186 related articles for article (PubMed ID: 34966482)
1. Comparative transcriptome analysis between patient and endometrial cancer cell lines to determine common signaling pathways and markers linked to cancer progression.
Cho-Clark MJ; Sukumar G; Vidal NM; Raiciulescu S; Oyola MG; Olsen C; Mariño-Ramírez L; Dalgard CL; Wu TJ
Oncotarget; 2021 Dec; 12(26):2500-2513. PubMed ID: 34966482
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and high-fat diet induced alterations in C57BL/6 mice endometrial transcriptome profile.
Cheng Y; Lv Q; Xie B; Yang B; Shan W; Ning C; Li B; Xie L; Gu C; Luo X; Chen X; Zhu Q
Endocr Connect; 2018 Jan; 7(1):36-46. PubMed ID: 29133384
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
Ying J; Wang Q; Xu T; Lyu J
Cancer Med; 2018 Jun; 7(6):2601-2611. PubMed ID: 29665298
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
Yang L; Cui Y; Sun X; Wang Y
Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
[TBL] [Abstract][Full Text] [Related]
5. Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Yadav VK; Lee TY; Hsu JB; Huang HD; Yang WV; Chang TH
PLoS One; 2020; 15(4):e0231594. PubMed ID: 32315343
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts.
Ma F; Laster K; Nie W; Liu F; Kim DJ; Lee MH; Bai R; Yang R; Liu K; Dong Z
J Cancer; 2021; 12(13):3930-3944. PubMed ID: 34093800
[TBL] [Abstract][Full Text] [Related]
7. An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
Elkahloun AG; Hafko R; Saavedra JM
Alzheimers Res Ther; 2016 Jan; 8():5. PubMed ID: 26822027
[TBL] [Abstract][Full Text] [Related]
8. Integrated Transcriptome and Multiple Activated Pathways in Endometrial Cancer.
Jin Q; Jiang X; Du X; Hu W; Bai S; Wang X; Xu B; Zhao W
Front Genet; 2021; 12():680331. PubMed ID: 34925436
[TBL] [Abstract][Full Text] [Related]
9. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
11. The Alzheimer's disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons.
George C; Gontier G; Lacube P; François JC; Holzenberger M; Aïd S
Brain; 2017 Jul; 140(7):2012-2027. PubMed ID: 28595357
[TBL] [Abstract][Full Text] [Related]
12. CDK4/RB/E2Fs axis as potential therapeutic target of endometrial cancer.
Hu J; Shen J; Sun J
Biomed Pharmacother; 2020 May; 125():109870. PubMed ID: 32032891
[TBL] [Abstract][Full Text] [Related]
13. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
[TBL] [Abstract][Full Text] [Related]
14. An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein-Protein Interaction Networks in Female-Specific Cancers.
Pane K; Affinito O; Zanfardino M; Castaldo R; Incoronato M; Salvatore M; Franzese M
Front Genet; 2020; 11():612521. PubMed ID: 33424936
[TBL] [Abstract][Full Text] [Related]
15. Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Song Y; Chen QT; He QQ
J Cell Biochem; 2019 Sep; 120(9):15443-15454. PubMed ID: 31037767
[TBL] [Abstract][Full Text] [Related]
16. Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundaries.
Lin EW; Karakasheva TA; Lee DJ; Lee JS; Long Q; Bass AJ; Wong KK; Rustgi AK
PLoS Genet; 2017 Aug; 13(8):e1006938. PubMed ID: 28787442
[TBL] [Abstract][Full Text] [Related]
17. OLA1 is a potential prognostic molecular biomarker for endometrial cancer and promotes tumor progression.
Dong Y; Yin A; Xu C; Jiang H; Wang Q; Wu W; Guo S
Oncol Lett; 2021 Aug; 22(2):576. PubMed ID: 34122627
[TBL] [Abstract][Full Text] [Related]
18. Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project.
Roque DR; Makowski L; Chen TH; Rashid N; Hayes DN; Bae-Jump V
Gynecol Oncol; 2016 Aug; 142(2):317-22. PubMed ID: 27288544
[TBL] [Abstract][Full Text] [Related]
19. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.
Guo S; Yang J; Wu M; Xiao G
Pathol Res Pract; 2019 May; 215(5):1003-1011. PubMed ID: 30910254
[TBL] [Abstract][Full Text] [Related]
20. Key factors mediated by PI3K signaling pathway and related genes in endometrial carcinoma.
Liu Z; Hong Z; Ma H; Yu D; Qu P
J Bioenerg Biomembr; 2020 Dec; 52(6):465-473. PubMed ID: 33159265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
